MicRhoGAM Side Effects: What to Expect and When to Call Your Doctor

MicRhoGAM (Rho(D) immune globulin mini-dose) is one of the safest and most well-studied biologics in obstetric medicine. It has been given to Rh-negative patients during pregnancy events since the 1960s, and serious adverse events are extremely rare. Understanding what to expect after your injection helps you tell the difference between a normal reaction and one that warrants a call to your provider.

Common Side Effects of MicRhoGAM

The most frequently reported side effects are mild and related to the injection itself:

Injection site reactions: Swelling, redness, induration (firmness), mild pain or warmth at the injection site. These are the most common reports and typically resolve within a few days.

Mild fever: A slight elevation in temperature may occur after administration. This is a known systemic response to the immune globulin and generally resolves on its own within 24–48 hours.

Body aches: Muscle aches or general malaise can occur in some patients, similar to other immune globulin products.

Skin rash: Mild skin rash has been reported rarely. If significant or spreading, contact your provider.

Serious Side Effects: Know the Warning Signs

Serious systemic reactions to MicRhoGAM are extremely rare. According to the prescribing information, there have been no reported fatalities due to anaphylaxis or any other cause related to MicRhoGAM administration. However, you should know the warning signs:

Anaphylaxis / Severe Allergic Reaction

Call 911 or go to the emergency room immediately if you experience any of the following after receiving MicRhoGAM:

Hives or generalized urticaria (itchy, raised welts across the body)

Tightness of the chest or difficulty breathing

Wheezing or audible breathing difficulty

Low blood pressure (feeling faint, dizzy, or lightheaded)

Rapid or weak pulse

This is why patients receiving MicRhoGAM should be observed for at least 20 minutes after administration in the clinical setting.

Positive Antibody Test in Newborn

The presence of passively acquired anti-D in the mother's blood (from MicRhoGAM) may cause a weakly positive direct antiglobulin (Coombs) test in some newborns if MicRhoGAM is given near the end of pregnancy. This is an expected laboratory finding and does NOT indicate harm to the baby. It also does not preclude further antepartum or postpartum RhIg prophylaxis.

Who Should Not Receive MicRhoGAM?

Rh(D)-positive individuals: MicRhoGAM is only for Rh-negative patients. Giving it to Rh-positive patients may cause a hemolytic reaction.

Already sensitized patients: Patients who already have anti-D antibodies (previously sensitized to Rh factor) do not benefit from MicRhoGAM.

Patients with known IgA deficiency with antibodies to IgA: Each dose of MicRhoGAM contains small amounts of IgA (<15 mcg); providers should weigh risks and benefits for these patients.

Impact on Vaccines

MicRhoGAM may impair the efficacy of live vaccines such as measles-mumps-rubella (MMR) and varicella. The prescribing information recommends delaying live vaccines until 12 weeks after the final dose. Similarly, if you recently received a live vaccine, wait at least 3 weeks before receiving MicRhoGAM unless clinically urgent. Discuss timing with your provider.

Breastfeeding Safety

Rho(D) immune globulin is frequently used in nursing mothers. IgG is a normal component of breast milk, and no adverse effects in breastfed infants have been reported.

For more on MicRhoGAM interactions, see our MicRhoGAM drug interactions guide. If you're having trouble finding MicRhoGAM in stock, medfinder can locate it at pharmacies near you.